Skip to search formSkip to main contentSkip to account menu

CPH 82

Known as: CPH-82 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

GlycosidesLignans

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
CPH-82 (Reumacon) versus auranofin (Ridaura): a 36-week study of their respective onset of action rates in RA.
The onset of action rate of CPH-82 (Reumacon), was compared with that of auranofin (AUR; Ridaura) in a 36-week randomised, double… 
1998
1998
Difference in pharmacological activity between CPH 82 and podophyllotoxin.
1993
1993
Corticosteroid effect of CPH-82.
A patient suffering from seronegative polyarthritis was treated with CPH-82 (Reumacon). During the treatment he developed a… 
1993
1993
Interference with the cortisol axis by the microtubule antagonist, CPH82.
Treatment with CPH 82, a mixture of two benzylidated podophyllotoxin glycosides, has been shown to improve inflammatory activity… 
1989
1989
The effect of CPH 82 on the growth of human lymphocytes in vitro. Definition of cytobiological action.
A drug composed of two semisynthetic podophylline derivatives, CPH 82, has recently been launched for the treatment of severe… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)